title: Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity.
abstract: Research integrating neuroimaging and molecular genetics has yielded important insights into how variability in brain chemistry predicts individual differences in brain function, behavior and related risk for psychopathology. However, existing studies have been limited by their focus on the independent effects of single polymorphisms with modest impact on brain chemistry. Here, we explored the effects of five functional polymorphisms affecting dopamine (DA) signaling on reward-related ventral striatum (VS) reactivity, measured with BOLD fMRI, in a sample of 69 Caucasians. We also compiled individual multilocus genetic profile scores reflecting the additive effects of alleles conferring relatively increased DA signaling across the five polymorphic loci: DAT1 9-repeat, DRD4 7-repeat, DRD2 -141C Del, DRD2 Taq1A C (A2), and COMT (158)Met. These multilocus DA profile scores accounted for 10.9% of the inter-individual variability in reward-related VS reactivity. In contrast, none of the individual polymorphisms accounted for significant variability. Our results show that biologically informed multilocus genetic profiles have unique promise as indices of variability in brain chemistry that may yield advances in mapping individual differences in behaviorally relevant brain function. In turn, such genetic profiles may fuel gene-environment interactions research establishing trajectories of risk for psychopathology.
authors: Department of Psychology and Neuroscience, Duke University, Durham, NC, USA.
authors: Yuliya S
authors: YS
authors: Nikolova
authors: Robert E
authors: RE
authors: Ferrell
authors: Stephen B
authors: SB
authors: Manuck
authors: Ahmad R
authors: AR
authors: Hariri
references: Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):617-22
references: 19104049
references: Nat Genet. 2002 Feb;30(2):149-50
references: 11799396
references: Neuropsychopharmacology. 2010 Jan;35(1):27-47
references: 19675534
references: Hum Brain Mapp. 2010 Feb;31(2):210-21
references: 19621370
references: Hum Mol Genet. 1997 Apr;6(4):577-82
references: 9097961
references: Nat Rev Neurosci. 2006 Jul;7(7):583-90
references: 16791147
references: Nat Rev Genet. 2009 Dec;10(12):872-8
references: 19859063
references: Hum Genet. 2010 Apr;127(4):441-52
references: 20084519
references: Cereb Cortex. 2011 Apr;21(4):896-910
references: 20810623
references: Neuroimage. 2010 Mar;50(1):184-9
references: 19900563
references: Science. 2010 Jul 30;329(5991):532
references: 20671181
references: Nat Neurosci. 2008 Dec;11(12):1381-2
references: 18978778
references: Arch Gen Psychiatry. 2009 Sep;66(9):966-975
references: 19736353
references: Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6269-74
references: 16569698
references: J Neurosci. 2006 Dec 20;26(51):13213-7
references: 17182771
references: Eur Neuropsychopharmacol. 2008 Dec;18(12):897-907
references: 18786813
references: Nat Neurosci. 2006 Nov;9(11):1362-3
references: 17013380
references: Biol Psychiatry. 2009 Jul 1;66(1):9-16
references: 19103437
references: Mol Psychiatry. 1999 May;4(3):290-6
references: 10395223
references: J Nucl Med. 2009 Jan;50(1):45-52
references: 19091889
references: Mol Psychiatry. 2007 Oct;12(10):893-5, 885
references: 17895922
references: Mol Psychiatry. 2008 May;13(5):544-56
references: 18180754
references: Nat Neurosci. 2004 Aug;7(8):887-93
references: 15235607
references: Nat Neurosci. 2010 Jan;13(1):25-7
references: 19904261
references: Annu Rev Neurosci. 2009;32:225-47
references: 19400720
references: Science. 2002 Jul 19;297(5580):400-3
references: 12130784
references: J Neurochem. 1995 Sep;65(3):1157-65
references: 7643093
references: Psychol Sci. 2010 Sep;21(9):1282-90
references: 20732903
references: Cereb Cortex. 2009 Nov;19(11):2499-507
references: 19321655
references: Pharmacol Rev. 2011 Mar;63(1):182-217
references: 21303898
references: Neuropsychopharmacology. 2004 Aug;29(8):1409-18
references: 15039770
references: Science. 2008 Oct 17;322(5900):449-52
references: 18927395
references: Neuroimage. 2008 Oct 1;42(4):1631-8
references: 18634888
references: J Neurosci. 2009 Mar 25;29(12):3695-704
references: 19321766
references: Mol Psychiatry. 2008 Jul;13(7):709-16
references: 18347599
references: BMC Genet. 2005 Nov 27;6:55
references: 16309561
references: Arch Gen Psychiatry. 1991 Jul;48(7):648-54
references: 2069496
references: Soc Cogn Affect Neurosci. 2009 Jun;4(2):158-65
references: 19174537
references: Am J Hum Genet. 2004 Nov;75(5):807-21
references: 15457404
references: Am J Hum Genet. 2004 May;74(5):931-44
references: 15077199
references: Behav Neurosci. 2010 Oct;124(5):633-44
references: 20939663
references: Neuroscience. 1995 Oct;68(4):963-8
references: 8545002
references: Mol Psychiatry. 2009 Jan;14(1):60-70
references: 17893706
references: Am J Med Genet. 1997 Apr 18;74(2):162-6
references: 9129716
references: Mol Psychiatry. 1998 May;3(3):256-60
references: 9672901
references: BMC Med Genet. 2007 Sep 19;8 Suppl 1:S15
references: 17903297
references: Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6917-22
references: 11381111
references: Nat Neurosci. 2010 Apr;13(4):419-21
references: 20228805
references: Science. 2007 Mar 2;315(5816):1267-70
references: 17332411
references: Proc Natl Acad Sci U S A. 2007 May 8;104(19):8125-30
references: 17483451
references: Neuropsychopharmacology. 2000 Feb;22(2):133-9
references: 10649826
references: Brain Res. 2006 Mar 3;1076(1):49-59
references: 16483551
references: Neuropsychologia. 2011 Mar;49(4):651-6
references: 20813118
references: Soc Cogn Affect Neurosci. 2012 Feb;7(2):213-21
references: 21183456
references: PLoS One. 2009 Aug 07;4(8):e6501
references: 19668339